{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:18:22Z","timestamp":1773458302425,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2006,9,15]],"date-time":"2006-09-15T00:00:00Z","timestamp":1158278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2006,11,7]]},"DOI":"10.1007\/s10620-006-9168-3","type":"journal-article","created":{"date-parts":[[2006,9,14]],"date-time":"2006-09-14T16:19:03Z","timestamp":1158250743000},"page":"2039-2044","source":"Crossref","is-referenced-by-count":40,"title":["Dopamine D2 Receptor Polymorphisms in Inflammatory Bowel Disease and the Refractory Response to Treatment"],"prefix":"10.1007","volume":"51","author":[{"given":"F.","family":"Magro","sequence":"first","affiliation":[]},{"given":"E.","family":"Cunha","sequence":"additional","affiliation":[]},{"given":"F.","family":"Araujo","sequence":"additional","affiliation":[]},{"given":"E.","family":"Meireles","sequence":"additional","affiliation":[]},{"given":"P.","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"M.","family":"Dinis-Ribeiro","sequence":"additional","affiliation":[]},{"given":"F. Tavarela","family":"Veloso","sequence":"additional","affiliation":[]},{"given":"R.","family":"Medeiros","sequence":"additional","affiliation":[]},{"given":"P.","family":"Soares-da-Silva","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2006,9,15]]},"reference":[{"key":"9168_CR1","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0167-5699(99)01510-8","volume":"20","author":"H Groux","year":"1999","unstructured":"Groux H, Powrie F (1999) Regulatory T cells and inflammatory bowel disease. Immunol Today 20:442\u2013445","journal-title":"Immunol Today"},{"key":"9168_CR2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0167-5699(97)01000-1","volume":"18","author":"W Strober","year":"1997","unstructured":"Strober W, Kelsall B, Fuss I, Marth T, Ludviksson B, Ehrhardt R, Neurath M (1997) Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today 18:61\u201364","journal-title":"Immunol Today"},{"key":"9168_CR3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng1096-199","volume":"14","author":"J Stangi","year":"1996","unstructured":"Stangi J, Parkes M, Louis E (1996) Two stage genoma-with search in inflammatory bowel disease provides evidence for susceptibility loci on chromossoma 3,7 and 12. Nat Genet 14:199\u2013202","journal-title":"Nat Genet"},{"key":"9168_CR4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","volume":"411","author":"JP Hugot","year":"2001","unstructured":"Hugot JP, Chamaillard M, Zouali H (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease. Nature 411:599\u2013603","journal-title":"Nature"},{"key":"9168_CR5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","volume":"411","author":"Y Ogura","year":"2001","unstructured":"Ogura Y, Bonen DK, Inohara N (2001) A frameshift mutation in NOD2 associated with susceptibility to Cohn\u2019s disease. Nature 411:603\u2013606","journal-title":"Nature"},{"key":"9168_CR6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1146\/annurev.pa.30.040190.003021","volume":"30","author":"S Ader","year":"1990","unstructured":"Ader S, Felton D, Cohn N (1990) Interactions between the brain and the immune system. Annu Rev Pharmacol Toxicol 30:561\u2013602","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"9168_CR7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-5728(99)00176-9","volume":"102","author":"S Basu","year":"2000","unstructured":"Basu S, Dasgupta PS (2000) Dopamine, a neurotransmitter, influences the immune system. J Neuroimmunol 102:113\u2013124","journal-title":"J Neuroimmunol"},{"key":"9168_CR8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0165-5728(02)00280-1","volume":"132","author":"F McKenna","year":"2002","unstructured":"McKenna F, Mclaughlin PJ, Lweis BJ, Sibbring GC, Cumerson JA, Bowen-Jones D (2002) Dopamine receptor expression on human T and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. J Neuroimmunol 132:34\u201340","journal-title":"J Neuroimmunol"},{"key":"9168_CR9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0165-5728(95)00004-L","volume":"58","author":"A Ricci","year":"1995","unstructured":"Ricci A, Vegilio F, Amenta F (1995) Radioligand binding characterization of putative dopamine D3 receptor in human peripheral blood lymphocytes with 3H-7-OH-DPAT. J Neuroimmunol 58:139\u2013144","journal-title":"J Neuroimmunol"},{"key":"9168_CR10","doi-asserted-by":"crossref","first-page":"12912","DOI":"10.1073\/pnas.91.26.12912","volume":"91","author":"J Bergquist","year":"1994","unstructured":"Bergquist J, Tarkowski A, Ekman R, Ewing A (1994) Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamines regulation of lymphocytes function via an autocrine loop. Proc Natl Acad Sci USA 91:12912\u201312916","journal-title":"Proc Natl Acad Sci USA"},{"key":"9168_CR11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1023\/A:1013256629600","volume":"47","author":"F Magro","year":"2002","unstructured":"Magro F, Vieira-Coelho MA, Fraga S, Serrao MP, Veloso FT, Ribeiro T, Soares-da-Silva P (2002) Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease. Dig Dis Sci 47:216\u2013224","journal-title":"Dig Dis Sci"},{"key":"9168_CR12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-201X.2004.01260.x","volume":"180","author":"F Magro","year":"2004","unstructured":"Magro F, Fraga S, Ribeiro T, Soares-da-Silva P (2004) Decreased availability of intestinal dopamine in transmural colitis may relate to inhibitory effects of interferon-gamma upon L-dopa uptake. Acta Physiol Scand 180:379\u2013386","journal-title":"Acta Physiol Scand"},{"issue":"8167","key":"9168_CR13","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","volume":"1","author":"RF Harvey","year":"1980","unstructured":"Harvey RF, Bradshaw JM (1980) A simple index of Crohn\u2019s disease activity. Lancet 1(8167):514","journal-title":"Lancet"},{"key":"9168_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004836-199501000-00008","volume":"20","author":"EJ Irvine","year":"1995","unstructured":"Irvine EJ (1995) Usual therapy improves Crohn\u2019s disease as measure a new disease activity index. McMaster Study Group. J Clin Gastroenterol 20:27\u201332","journal-title":"J Clin Gastroenterol"},{"key":"9168_CR15","first-page":"1041","volume":"4947","author":"SC Truelove","year":"1995","unstructured":"Truelove SC, Witts LJ (1995) Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 4947:1041\u20131048","journal-title":"Br Med J"},{"key":"9168_CR16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/gut.35.3.360","volume":"35","author":"P Munkholm","year":"1994","unstructured":"Munkholm P, Langholz E, Davidsen M, Binder V (1994) Frequency of glucocorticoid resistance and dependency in Crohn\u2019s disease. Gut 35:360\u2013362","journal-title":"Gut"},{"key":"9168_CR17","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/sj.gene.6364123","volume":"5","author":"U Potocnik","year":"2004","unstructured":"Potocnik U, Ferkolj I, Glavac D, Dean M (2004) Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn\u2019s disease and ulcerative colitis. Genes and Immunity 5:530\u2013539","journal-title":"Genes and Immunity"},{"key":"9168_CR18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/jnci\/90.5.358","volume":"90","author":"MR Spitz","year":"1998","unstructured":"Spitz MR, Shi H, Yang F, Hudmon KS, Jiang H, Chamberlain RM, Amos CI, Wan Y, Cinciripini P, Hong WK, Wu X (1998) Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst 90:358\u2013363","journal-title":"J Natl Cancer Inst"},{"key":"9168_CR19","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2249.1995.tb03130.x","volume":"101","author":"M Niessner","year":"1995","unstructured":"Niessner M, Volk BA (1995) Altered Th1\/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reverse transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 101:428\u2013435","journal-title":"Clin Exp Immunol"},{"key":"9168_CR20","first-page":"127","volume":"78","author":"E Breese","year":"1993","unstructured":"Breese E, Braegger CP, Corrigan CJ (1993). Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunol Today 78:127\u2013131","journal-title":"Immunol Today"},{"key":"9168_CR21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.med.51.1.289","volume":"51","author":"KA Papadakis","year":"2000","unstructured":"Papadakis KA, Targan SR (2000) Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med 51:289\u2013298","journal-title":"Annu Rev Med"},{"key":"9168_CR22","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1136\/gut.2004.040824","volume":"53","author":"MP Peppelenbosch","year":"2004","unstructured":"Peppelenbosch MP, Deventer SJ (2004) T cell apoptosis and inflammatory bowel disease. Gut 53:1556\u20131558","journal-title":"Gut"},{"key":"9168_CR23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S1567-5769(03)00100-0","volume":"3","author":"MC Ghosh","year":"2003","unstructured":"Ghosh MC, Mondal AC, Basu S, Banerjee S, Majumber J, Bhattacharya D, Dasgupta PA (2003) Dopamine inhibits cytokine release and expression of tyrosine kinases, LCK and Fyn in activated T cells. Int Immunopharmacol 3:1019\u20131026","journal-title":"Int Immunopharmacol"},{"key":"9168_CR24","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1128\/MCB.20.4.1426-1435.2000","volume":"20","author":"MF Denny","year":"2000","unstructured":"Denny MF, Patai B, Strauss DB (2000) Differential T-cell antigen receptor signaling mediated by Src family kinases Lck and Fyn. Mol Cell Biol 20:1426\u20131435","journal-title":"Mol Cell Biol"},{"key":"9168_CR25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0955-0674(97)80064-6","volume":"9","author":"D Qian","year":"1997","unstructured":"Qian D, Weiss A (1997) T cell antigen receptor signal transduction. Curr Opin Cell Biol 9:205\u2013212","journal-title":"Curr Opin Cell Biol"},{"key":"9168_CR26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2249.1994.tb07028.x","volume":"95","author":"K Morikawa","year":"1994","unstructured":"Morikawa K, Oseko F, Morikawa S (1994) Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro. Clin Exp Immunol 95:514\u2013518","journal-title":"Clin Exp Immunol"},{"key":"9168_CR27","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/ana.410290514","volume":"29","author":"PN Riskind","year":"1991","unstructured":"Riskind PN, Massacesi L, Doolittle TH, Hauser SL (1991) The role of prolactin in autoimmune demyelination: suppression of experimental allergic encepalomyelitis by bromocriptine. Ann Neurol 29:542\u2013547","journal-title":"Ann Neurol"},{"key":"9168_CR28","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/elps.1150181009","volume":"18","author":"J Bergquist","year":"1997","unstructured":"Bergquist J, Josefsson E, Tarkowski A, Ekman R, Ewing A (1997) Measurements of catecholamine-mediated apoptosis of immunocompetent cells by capillary electrophoresis. Electrophoresis 18:1760\u20131766","journal-title":"Electrophoresis"},{"key":"9168_CR29","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1196\/annals.1299.124","volume":"1010","author":"C Colombo","year":"2003","unstructured":"Colombo C, Cosentino M, Marino F, Rasini E, Ossola M, Blandini F, Mangiagalli A, Samuele A, Ferrari M, Bombelli R, Lecchini S, Nappi G, Frigo G (2003) Dopaminergic modulation of apoptosis in human blood mononuclear cells: possible relevance of Parkinson\u2019s disease. Ann N Y Acad Sci 1010:679\u2013682","journal-title":"Ann N Y Acad Sci"},{"key":"9168_CR30","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/rheumatology\/36.9.1022","volume":"36","author":"FE Figueroa","year":"1997","unstructured":"Figueroa FE, Carrion F, Martinnez ME, Rivero S, Mamani L (1997) Bromocriptine induces immunological changes related to disease parameters in rheumatoid arthritis. Br J Rheumatol 36:1022\u20131023","journal-title":"Br J Rheumatol"},{"key":"9168_CR31","first-page":"2084","volume":"22","author":"RW McMurray","year":"1995","unstructured":"McMurray RW, Weidensaul D, Allen SH, Walker SE (1995) Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. J Reumatol 22:2084\u20132091","journal-title":"J Reumatol"},{"key":"9168_CR32","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0190-9622(87)80135-4","volume":"16","author":"G Weber","year":"1987","unstructured":"Weber G, Frey H (1987) Treatment of psoriatic arthritis with bromocriptine. J Am Acad Dermatol 16:388\u2013389","journal-title":"J Am Acad Dermatol"},{"key":"9168_CR33","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1053\/gast.2001.29467","volume":"121","author":"RE Kast","year":"2001","unstructured":"Kast RE, Altschuler EL (2001) Remission of Crohn\u2019s disease on Bupropion. Gastroenterol 121:1260\u20131261","journal-title":"Gastroenterol"},{"key":"9168_CR34","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/(SICI)1097-0231(19980615)12:11<683::AID-RCM218>3.0.CO;2-N","volume":"12","author":"J Bergquist","year":"1998","unstructured":"Bergquist J, Silberring J (1998) Identification of catecholamines in the immune system by electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom 12:683\u2013688","journal-title":"Rapid Commun Mass Spectrom"},{"key":"9168_CR35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1365-2567.1996.d01-653.x","volume":"88","author":"E Josefsson","year":"1996","unstructured":"Josefsson E, Bergquist J, Ekman R, Tarkowski A (1996) Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology 88:140\u2013146","journal-title":"Immunology"},{"key":"9168_CR36","first-page":"PL335","volume":"62","author":"CW Tsao","year":"1998","unstructured":"Tsao CW, Lin YS, Cheng JT (1998) Inhibition of immune cell proliferation with haloporinol and relationship of tyrosine hydroxylase expression to immune cell growth. Life Sci 62:PL335\u2013PL344","journal-title":"Life Sci"},{"key":"9168_CR37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0165-5728(98)00207-0","volume":"92","author":"A Ricci","year":"1998","unstructured":"Ricci A, Bronzetti E, Felici L, Greco S, Amenta F (1998) Labeling of dopamine D3 and D4 receptor subtypes in human peripheral blood lymphocytes with 3H7-OH-DPAT: a combined radioligand binding assay and immunochemical study. J Neuroimmunol 92:191\u2013195","journal-title":"J Neuroimmunol"},{"key":"9168_CR38","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0165-5728(99)00042-9","volume":"96","author":"A Ricci","year":"1999","unstructured":"Ricci A, Bronzetti E, Mignini F, Tayebati SK, Zaccheo D, Amenta F (1999) Dopamine d1-like receptor subtypes in human peripheral blood lymphocytes. J Neuroimmunol 96:234\u2013240","journal-title":"J Neuroimmunol"},{"key":"9168_CR39","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1002\/1521-4141(200112)31:12<3504::AID-IMMU3504>3.0.CO;2-F","volume":"31","author":"M Levite","year":"2001","unstructured":"Levite M, Chowers Y, Ganor Y, Besser M, Hershkovits R, Cahalon L (2001) Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates beta 1 integrin function. Eur J Immunol 31:3504\u20133512","journal-title":"Eur J Immunol"},{"key":"9168_CR40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev.pa.33.040193.001433","volume":"32","author":"O Civelli","year":"1993","unstructured":"Civelli O, Buzow JR, Grandy DK (1993) Molecular diversity of dopamine receptors. Annu Rev Pharmacol Toxicol 32:281\u2013307","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"9168_CR41","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev.ne.16.030193.001503","volume":"16","author":"JA Gingrich","year":"1993","unstructured":"Gingrich JA, Caron MG (1993) Recent advances in molecular biology of dopamine receptors. Annu Rev Neurosci 16:299\u2013321","journal-title":"Annu Rev Neurosci"},{"key":"9168_CR42","first-page":"778","volume":"45","author":"DK Grandy","year":"1989","unstructured":"Grandy DK, Litt M, Allen L, Bunzow JR, Marchionni M, Makam H, Reed L, Magenis RE, Civelli O (1989) The human D(2) dopamine receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet 45:778\u2013785","journal-title":"Am J Hum Genet"},{"key":"9168_CR43","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1001\/archpsyc.1991.01810310066012","volume":"48","author":"EP Noble","year":"1991","unstructured":"Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ (1991) Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psych 48:648\u2013654","journal-title":"Arch Gen Psych"},{"key":"9168_CR44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0306-9877(94)90127-9","volume":"42","author":"EP Noble","year":"1994","unstructured":"Noble EP, St Jeor ST, Ritchie T, Syndulko K, St Jeor SC, Fitch RJ, Brunner RL, Sparkes RS (1994) D2 dopamine receptor gene and cigarette smoking: a reward gene? Med Hypotheses 42:257\u2013260","journal-title":"Med Hypotheses"},{"key":"9168_CR45","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/ajcn\/80.1.82","volume":"80","author":"LH Epstein","year":"2004","unstructured":"Epstein LH, Wright SM, Paluch RA, Leddy JJ, Hawk LWJ, Jaroni JL, Saad FG, Crystal-Mansour S, Shields PG, Lerman C (2004) Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers. Am J Clin Nutr 80:82\u201388","journal-title":"Am J Clin Nutr"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-006-9168-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-006-9168-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-006-9168-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T19:35:49Z","timestamp":1559244949000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-006-9168-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,15]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11,7]]}},"alternative-id":["9168"],"URL":"https:\/\/doi.org\/10.1007\/s10620-006-9168-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,15]]}}}